Current world literature.
出版信息
Curr Opin Urol. 2013 Jul;23(4):377-88. doi: 10.1097/MOU.0b013e328362c382.
PMID:23735869
Abstract
摘要
相似文献
1
Current world literature.
Curr Opin Urol. 2013 Jul;23(4):377-88. doi: 10.1097/MOU.0b013e328362c382.
2
[Treatment of prostate cancer].[前列腺癌的治疗]
Orv Hetil. 2010 Apr 4;151(14):580-3. doi: 10.1556/OH.2010.28810.
3
[Combined treatment of metastatic hormone-resistant prostate cancer].[转移性激素抵抗性前列腺癌的联合治疗]
Vopr Onkol. 2009;55(4):477-9.
4
Words of wisdom: Re: High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study [abstract 3].智慧之言：关于：盆腔放疗联合36个月与18个月雄激素阻断治疗高危前列腺癌：一项III期随机研究的结果[摘要3]
Eur Urol. 2013 Sep;64(3):513. doi: 10.1016/j.eururo.2013.06.028.
5
[Prostate cancer: evolution of approach].
Vopr Onkol. 2009;55(2):241-9.
6
The changing face of hormonal therapy for prostate cancer.
Ann Oncol. 2008 Sep;19 Suppl 7:vii79-85. doi: 10.1093/annonc/mdn477.
7
[Treatment of prostate cancer].[前列腺癌的治疗]
Orv Hetil. 2005 Aug 28;146(35):1839-42.
8
Adjuvant treatment to surgery.
BJU Int. 2007 Jul;100 Suppl 2:40-3. doi: 10.1111/j.1464-410X.2007.06953.x.
9
10
Current world literature.当前世界文献。
Curr Opin Urol. 2012 Jul;22(4):336-45. doi: 10.1097/MOU.0b013e3283551cbf.
Zotero 插件